These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8247096)

  • 21. Effects of immunoglobulin G and low-dose amphotericin B on Candida albicans infections in burned mice.
    Neely AN; Holder IA
    Antimicrob Agents Chemother; 1992 Mar; 36(3):643-6. PubMed ID: 1622177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative therapeutic efficacy of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and deoxycholate-amphotericin B in immunocompetent and neutropenic mice infected with Candida albicans.
    Brime B; Molero G; Frutos P; Frutos G
    Eur J Pharm Sci; 2004 Aug; 22(5):451-8. PubMed ID: 15265515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients.
    Mills W; Chopra R; Linch DC; Goldstone AH
    Br J Haematol; 1994 Apr; 86(4):754-60. PubMed ID: 7918068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of experimental murine candidiasis with liposome-encapsulated amphotericin B].
    Sasahara T
    Kansenshogaku Zasshi; 1989 Dec; 63(12):1301-7. PubMed ID: 2621383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.
    van Etten EW; Otte-Lambillion M; van Vianen W; ten Kate MT; Bakker-Woudenberg AJ
    J Antimicrob Chemother; 1995 Apr; 35(4):509-19. PubMed ID: 7628985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis.
    Kretschmar M; Nichterlein T; Hannak D; Hof H
    Arzneimittelforschung; 1996 Jul; 46(7):711-5. PubMed ID: 8842344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida tropicalis.
    Gelfand MS
    Infect Control Hosp Epidemiol; 1989 Jun; 10(6):280-3. PubMed ID: 2661684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy.
    Schinabeck MK; Long LA; Hossain MA; Chandra J; Mukherjee PK; Mohamed S; Ghannoum MA
    Antimicrob Agents Chemother; 2004 May; 48(5):1727-32. PubMed ID: 15105127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B.
    Smith PJ; Olson JA; Constable D; Schwartz J; Proffitt RT; Adler-Moore JP
    J Antimicrob Chemother; 2007 May; 59(5):941-51. PubMed ID: 17400589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined effect of liposomal and conventional amphotericin B in a mouse model of systemic infection with Candida albicans.
    Kretschmar M; Bertsch T; Nichterlein T
    J Chemother; 2004 Jun; 16(3):255-8. PubMed ID: 15330321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles.
    Brajtburg J; Elberg S; Travis SJ; Kobayashi GS
    Antimicrob Agents Chemother; 1994 Feb; 38(2):294-9. PubMed ID: 8192455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits.
    Groll AH; Petraitis V; Petraitiene R; Field-Ridley A; Calendario M; Bacher J; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2463-7. PubMed ID: 10508025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of experimental murine candidiasis with liposome-associated amphotericin B.
    Ahrens J; Graybill JR; Craven PC; Taylor RL
    Sabouraudia; 1984; 22(2):163-6. PubMed ID: 6729660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice.
    Tremblay C; Barza M; Fiore C; Szoka F
    Antimicrob Agents Chemother; 1984 Aug; 26(2):170-3. PubMed ID: 6385839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP
    J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a new formulation of amphotericin B in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2008 Apr; 61(4):880-3. PubMed ID: 18256113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans.
    Ortoneda M; Capilla J; Pujol I; Pastor FJ; Mayayo E; Fernández-Ballart J; Guarro J
    J Antimicrob Chemother; 2002 Mar; 49(3):525-9. PubMed ID: 11864953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of fungicidal activity against Candida tropicalis on the efficacy of micafungin and liposomal amphotericin B in a neutropenic murine lethal infection model.
    Takemoto K; Nakayama T; Kanazawa K; Ueda Y
    Pharmacology; 2012; 90(3-4):133-45. PubMed ID: 22847175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis.
    Kirsh R; Goldstein R; Tarloff J; Parris D; Hook J; Hanna N; Bugelski P; Poste G
    J Infect Dis; 1988 Nov; 158(5):1065-70. PubMed ID: 3183418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.